XDWH.L
XDWH.L
About Xtrackers MSCI World Health Care UCITS ETF 1C
The MSCI World Health Care TRN Index aims to reflect the performance of the following market: Large and mid-cap companies from global developed markets part of the Health care sector as classified by GICS Weighted by free-float adjusted market capitalisation Reviewed on a quarterly basis Additional information on the index, selection and weighting methodology is available at https://www.msci.com
About Xtrackers MSCI World Health Care UCITS ETF 1C
The MSCI World Health Care TRN Index aims to reflect the performance of the following market: Large and mid-cap companies from global developed markets part of the Health care sector as classified by GICS Weighted by free-float adjusted market capitalisation Reviewed on a quarterly basis Additional information on the index, selection and weighting methodology is available at https://www.msci.com
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 LLY | Eli Lilly and Company | 10.64% | 365.50K | $402.50M |
 JNJ | Johnson & Johnson | 5.97% | 1.09M | $225.62M |
 ABBV | AbbVie Inc. | 4.92% | 821.90K | $186.18M |
 UNH | UnitedHealth Group Incorporated | 3.69% | 402.36K | $139.73M |
 MRK | Merck & Co., Inc. | 3.24% | 1.10M | $122.48M |
 TMO | Thermo Fisher Scientific Inc. | 2.78% | 170.49K | $105.22M |
 ABT | Abbott Laboratories | 2.64% | 782.27K | $99.83M |
 ISRG | Intuitive Surgical, Inc. | 2.53% | 163.47K | $95.86M |
 AMGN | Amgen Inc. | 2.20% | 246.62K | $83.04M |
 GILD | Gilead Sciences, Inc. | 1.84% | 570.71K | $69.67M |
 DHR | Danaher Corporation | 1.81% | 289.94K | $68.55M |
 BSX | Boston Scientific Corporation | 1.75% | 660.12K | $66.02M |
 PFE | Pfizer Inc. | 1.72% | 2.55M | $64.90M |
 SYK | Stryker Corporation | 1.51% | 154.64K | $57.13M |
 VRTX | Vertex Pharmaceuticals Incorporated | 1.48% | 115.96K | $56.06M |
 BMY | Bristol-Myers Squibb Company | 1.38% | 920.41K | $52.13M |
 MCK | McKesson Corporation | 1.22% | 56.45K | $46.32M |
 CVS | CVS Health Corporation | 1.21% | 568.52K | $45.73M |
 REGN | Regeneron Pharmaceuticals, Inc. | 1.01% | 46.74K | $38.15M |
 HCA | HCA Healthcare, Inc. | 0.92% | 72.73K | $34.76M |
SECTOR HOLDINGS
Healthcare
Consumer Defensive
Cash & OthersASSET ALLOCATION BY REGION
United States
Switzerland
United Kingdom
Japan
France
Denmark
Ireland
Germany
Australia
Netherlands
Belgium
Israel
New Zealand
Luxembourg
Finland
Sweden
Italy
SpainSECTOR HOLDINGS
Healthcare Consumer Defensive Cash & OthersASSET ALLOCATION BY REGION
United States Switzerland United Kingdom Japan France Denmark Ireland Germany Australia Netherlands Belgium Israel New Zealand Luxembourg Finland Sweden Italy SpainHoldings (Top 20)
LLY
Eli Lilly and Company
JNJ
Johnson & Johnson
ABBV
AbbVie Inc.
UNH
UnitedHealth Group Incorporated
MRK
Merck & Co., Inc.
TMO
Thermo Fisher Scientific Inc.
ABT
Abbott Laboratories
ISRG
Intuitive Surgical, Inc.
AMGN
Amgen Inc.
GILD
Gilead Sciences, Inc.
DHR
Danaher Corporation
BSX
Boston Scientific Corporation
PFE
Pfizer Inc.
SYK
Stryker Corporation
VRTX
Vertex Pharmaceuticals Incorporated
BMY
Bristol-Myers Squibb Company
MCK
McKesson Corporation
CVS
CVS Health Corporation
REGN
Regeneron Pharmaceuticals, Inc.
HCA
HCA Healthcare, Inc.